Pfizer Posts Better Than Expected

Media Summary: Louise Chen of Cantor Fitzgerald discusses CNBC's Meg Tirrell joins 'Squawk Box' to break down Pete Najarian, Degas Wright and Joe Terranova join the Halftime Report to discuss

Pfizer Posts Better Than Expected - Detailed Analysis & Overview

Louise Chen of Cantor Fitzgerald discusses CNBC's Meg Tirrell joins 'Squawk Box' to break down Pete Najarian, Degas Wright and Joe Terranova join the Halftime Report to discuss

Photo Gallery

Pfizer posts better-than-expected Q3 earnings

Pfizer Q2 earnings: $0.78 per share vs $0.66 EPS expected

Pfizer beats earnings expectations, raising full-year guidance

There's still upside to Pfizer's better-than-expected earnings: Analyst

Pfizer posts earnings miss, revenue beat

Pfizer beats EPS estimates; stock falls on lower yearly guidance

Pfizer forecasts $15 billion in revenue from Covid-19 vaccine in 2021

Pfizer lifts profit view on cost cuts | REUTERS

Pfizer posts light EPS beat but misses on revenue in Q3

Pfizer beats on Q4 earnings, issues weak guidance for COVID-19 vaccine

Pfizer issues weak guidance despite Q4 earnings beat

Merck, Pfizer post earnings beats

View Detailed Profile

Pfizer posts better-than-expected Q3 earnings

Pfizer posts better-than-expected Q3 earnings

CNBC's 'Squawk Box' team breaks down

Pfizer Q2 earnings: $0.78 per share vs $0.66 EPS expected

Pfizer Q2 earnings: $0.78 per share vs $0.66 EPS expected

CNBC's Meg Tirrell breaks down

Pfizer beats earnings expectations, raising full-year guidance

Pfizer beats earnings expectations, raising full-year guidance

97 cents per share

There's still upside to Pfizer's better-than-expected earnings: Analyst

There's still upside to Pfizer's better-than-expected earnings: Analyst

Louise Chen of Cantor Fitzgerald discusses

Pfizer posts earnings miss, revenue beat

Pfizer posts earnings miss, revenue beat

"Squawk Box" reports on

Pfizer beats EPS estimates; stock falls on lower yearly guidance

Pfizer beats EPS estimates; stock falls on lower yearly guidance

CNBC's Meg Tirrell reports on

Pfizer forecasts $15 billion in revenue from Covid-19 vaccine in 2021

Pfizer forecasts $15 billion in revenue from Covid-19 vaccine in 2021

CNBC's Meg Tirrell breaks down

Pfizer lifts profit view on cost cuts | REUTERS

Pfizer lifts profit view on cost cuts | REUTERS

Pfizer

Pfizer posts light EPS beat but misses on revenue in Q3

Pfizer posts light EPS beat but misses on revenue in Q3

CNBC's Meg Tirrell breaks down

Pfizer beats on Q4 earnings, issues weak guidance for COVID-19 vaccine

Pfizer beats on Q4 earnings, issues weak guidance for COVID-19 vaccine

Pfizer

Pfizer issues weak guidance despite Q4 earnings beat

Pfizer issues weak guidance despite Q4 earnings beat

Pfizer

Merck, Pfizer post earnings beats

Merck, Pfizer post earnings beats

"Squawk Box" reports on Merck's and

Pfizer reports first-quarter earnings, records $13.2 billion in Covid vaccine revenue

Pfizer reports first-quarter earnings, records $13.2 billion in Covid vaccine revenue

CNBC's Meg Tirrell joins 'Squawk Box' to break down

More Mandates Expected As Pfizer Vaccine Gets Full FDA Approval

More Mandates Expected As Pfizer Vaccine Gets Full FDA Approval

The FDA has now given the

Pfizer posts unexpected Q4 earnings beat

Pfizer posts unexpected Q4 earnings beat

Pfizer

Pfizer beats profit estimates on cost cuts, COVID vaccine sales | REUTERS

Pfizer beats profit estimates on cost cuts, COVID vaccine sales | REUTERS

Drugmaker

Pfizer beats on top and bottom lines

Pfizer beats on top and bottom lines

CNBC's Joe Kernen reports on

Pfizer is more than a Covid play

Pfizer is more than a Covid play

Pete Najarian, Degas Wright and Joe Terranova join the Halftime Report to discuss

Pfizer expected to hike U.S. COVID vaccine price to $110-$130 per dose

Pfizer expected to hike U.S. COVID vaccine price to $110-$130 per dose

Pfizer

‘Win-win’: Pfizer vaccine profits benefits Portage

‘Win-win’: Pfizer vaccine profits benefits Portage

Pfizer's

Related Video Content

Pfizer: One of the world's premier biopharmaceutical companies information

Starting with Charles Pfizer inventing an almond-flavored antiparasite medicine in 1849, our people have always been...

Pfizer - Wikipedia information

Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest...

PfizerForAll™ | Official Site information

We’re committed to helping you afford your Pfizer prescriptions. From co-pay cards to self-pay savings and help...

Pfizer - LinkedIn information

Pfizer | 7,006,621 followers on LinkedIn. We’re celebrating over 175 years of daring scientific innovation—and we’re...

Search for Jobs information

Pfizer careers are like no other. In our culture of individual ownership, we believe in our ability to improve future...